STAGE II LUNG CANCER AJCC V8

This study looked at 20 adults with stage 2-3 non-small cell lung cancer that could not be removed by surgery. Participants received standard chemotherapy along with different doses of proton beam therapy to find the safest and most effective dose. The goal was to improve cancer …

This early-stage trial tested whether adding immunotherapy drugs (durvalumab, monalizumab, or oleclumab) to radiation therapy is safe for people with advanced non-small cell lung cancer that cannot be removed by surgery. The study involved 26 participants and focused on side effe…

This study tested whether the immunotherapy drug pembrolizumab can prevent lung cancer in 45 people with early-stage non-small cell lung cancer or suspicious lung nodules. Participants received the drug and were monitored for tumor response and survival. The goal was to see if bo…

This early-phase trial tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein (EGF) that can fuel cancer growth. Researchers measured immune response…

This study involved 24 people with lung or esophageal cancer receiving radiation therapy near the heart. Researchers used a small implanted device to continuously monitor heart activity for up to a year. The goal was to detect early heart changes that might otherwise go unnoticed…